CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
WallFlex Biliary Fully Covered Stentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01151280
NCT01151280N/ACompleted
CompareCT.gov

A Multi-Center, Prospective Study the WallFlex Biliary RX Fully Covered Stent for the Treatment of Anastomotic Biliary Strictures in Post Liver Transplant Patients.

Boston Scientific Corporation·interventional·Posted Jun 28, 2010·Updated Dec 25, 2013

In Brief

A clinical study evaluating WallFlex Biliary Fully Covered Stent for Anastomotic Biliary Stricture Post Orthotopic Liver Transplant. Completed, enrolled 10 participants across 2 sites.

Detailed Summary

The primary objective of this study is to demonstrate effectiveness of the WallFlex Biliary RX Fully Covered Stent for anastomotic biliary strictures in post-orthotopic liver transplant (OLT) patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnastomotic Biliary Stricture Post Orthotopic Liver Transplant
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 28, 2010
Enrollment StartOct 1, 2009
Primary CompletionOct 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 16.0 years ago

Interventions

WallFlex Biliary Fully Covered Stentdevice

Investigational device evaluated for the treatment for benign biliary strictures